Parnell Pharmaceuticals Holdings Ltd (CE) (PARNF) Actualités

Confidential Treatment Order (ct Order)

Amended Report of Foreign Issuer (6-k/a)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549        ...

Annual and Transition Report (foreign Private Issuer) (20-f)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     &n...

Report of Foreign Issuer (6-k)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form...

Amended Statement of Ownership (sc 13g/a)

SCHEDULE 13G Amendment No. 1 PARNELL PHARMACEUTICALS HLDGS LTD COMMON STOCK Cusip #Q73622104 Check the appropriate...

Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF...

Post-effective Amendment to Registration Statement (pos Am)

  As filed with the Securities and Exchange Commission on December 21, 2016   Registration No...

Post-effective Amendment to Registration Statement (pos Am)

  As filed with the Securities and Exchange Commission on December 21, 2016   Registration No...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

    As filed with the Securities and Exchange Commission on December 21...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

    As filed with the Securities and Exchange Commission on December 21...

(25)

          UNITED STATES SECURITIES AND EXCHANGE...

Report of Foreign Issuer (6-k)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form...

Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ

OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated...